Formulation and Evaluation of Tacrolimus Transdermal Gel
The present investigation is concerned with formulation and evaluation of Transdermal gels of Tacrolimus, anti-psoriasis drug, to circumvent the first pass effect and to improve its bioavailability with reduction in dosing frequency and dose related side effects. Twelve formulations were developed with varying concentrations of polymers like Carbopol 934P, HPMCK4M and Sodium CMC. The gels were tested for clarity, Homogeneity, Spreadability, Extrudability, Viscosity, surface pH, drug Content uniformity, in-vitro drug diffusion study and ex-vivo permeation study using rat abdominal skin. FTIR studies showed no evidence on interactions between drug, polymers and excipients. The best in-vitro drug release profile was achieved with the formulation F4 containing 0.5 mg of exhibited 6 hr drug release i.e. 98.68 % with desired therapeutic concentration which contains the drug and Carbopol 934p in the ratio of 1:2. The surface pH, drug content and viscosity of the formulation F4 was found to be 6.27, 101.3% and 3, 10,000cps respectively. The drug permeation from formulation F4 was slow and steady and 0.89gm of tacrolimus could permeate through the rat abdominal skin membrane with a flux of 0.071 gm hr-1 cm-2. The in-vitro release kinetics studies reveal that all formulations fit well with zero order kinetics followed by non-Fickian diffusion mechanism.
Keywords: Transdermal gel, Viscosity, In-vitro drug release, In-vitro drug release kinetics study, Ex-vivo permeation study
2. Langer R. Transdermal Drug Delivery: Past progress, current status and future prospects. Adv Drug Deliv Rev. 2004; 56:557-558.
3. Barry Transdermal Drug Delivery. In Aulton ME, Pharmaceutics. The science of dosage formdesign2nd ed. Churchill, Livingstone, 2002;499-543
4. Idson B Jack Semisolids. In Lachmann LLiebermannH Aand Kanig JL. The Theory and Practice of Industrial Pharmacy, 3rd ed. Bombay: Varghese Publishing House, 1990;534-563.
5. PenaLE. Gel dosage form Theory, Formulation and Processing. In Osborne DW, Amann AH. Topical drug delivery formulation. NewYork, Marcel Dekker; 1990; 381-388.
6. Alberto B Clinical pharmacokinetic sand metabolism of Nimesulide in flammopharmacology. 2001; 9:81-89.
7. Sankar SV., Chandrasekharan AK., DurgaS., Prasanth KG., NilaniP., Formulation and stability evaluation of diclofenac sodium ophthalmic gels. Ind.J. Pharm.Sci. 2005; 67(4):473-476.Lakshmi P K.,Marka K K., Aishwarya S Shyamala B.,
8. Formulation and evaluation of Ibuprofen Topical gel A Novel approach for penetration enhancement. Int. J. Applied Pharm. 2011; 3 (3):25-30.
9. Swamy N.G.N., MazharP., ZaheerA., Formulation and evaluation of Diclofenac sodium gelsusing Sodium carboxymethyl Hydroxypropyl Guar and Hydroxypropyl methylcellulose. Indian J. Pharm. EducRes. 2010; 44 (4):310-314.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).